Live Breaking News & Updates on India Managing Director Vikrant

Stay updated with breaking news from India managing director vikrant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Novo Nordisk eyes to bring blockbuster weight-loss drug Wegovy to India in 2026

Novo charges more than $1300 in the U.S. for a monthly supply and about 300 euros ($317) a month in Germany. ....

United Kingdom , Vikrant Shrotriya , Eli Lilly Mounjaro , National Family Health , Novo Nordisk , India Managing Director Vikrant , Eli Lilly , National Family Health Survey , Novo Nordisk India , Weight Loss , Weight Loss Drug ,

Wegovy: Novo Nordisk India head eyes 2026 launch for obesity drug Wegovy, warns against copycats

Novo Nordisk plans to bring its weight-loss drug, Wegovy, to India in 2026. The company aims to secure regulatory approvals and ensure sufficient supply before entering the Indian market, where obesity rates are high. Counterfeit versions of Wegovy are already being sold online, but Novo Nordisk urges patients not to buy them due to safety concerns. ....

United Kingdom , Eli Lilly Mounjaro , Vikrant Shrotriya , National Family Health , Healthcare Management Analytics Programme , Novo Nordisk , Offering College , Indian School Of Business , Healthcare Expertise , India Managing Director Vikrant , Eli Lilly , National Family Health Survey , Obesity Rates , Blockbuster Weight Loss ,

Novo Nordisk India head eyes 2026 Wegovy launch, warns against copycats

Danish drugmaker Novo
Nordisk aims to bring its blockbuster weight-loss
drug Wegovy to India in 2026, after securing regulatory
approvals and ensuring it has enough supply to meet demand, a
top. ....

United Kingdom , Eli Lilly Mounjaro , Dhanya Skariachan , Michele Gershberg , Sonali Paul , Vikrant Shrotriya , National Family Health , Novo Nordisk , India Managing Director Vikrant , Eli Lilly , National Family Health Survey ,